Trial Outcomes & Findings for Tango for Treatment of Motor and Non-motor Manifestations in Parkinson's Disease. (NCT NCT01573260)

NCT ID: NCT01573260

Last Updated: 2016-02-01

Results Overview

This is the standard scale used for grading severity of PD. It starts with a patient self-administered questionnaire covering activities of daily living, motor symptoms, and non-motor domains. It also includes a systematic rated clinical interview assessing cognitive and psychiatric symptoms and motor complications of disease. A Hoehn and Yahr scale (5-point overall disease severity index) is included. Finally, there is a formal examination component (Part III) (performed in the medication 'on' state for this study). Total score for Unified Parkinson Disease Rating Scale is the sum of six subscales, ranging from 0 (best possible outcome) to 60 (worst possible symptoms)

Recruitment status

COMPLETED

Study phase

EARLY_PHASE1

Target enrollment

33 participants

Primary outcome timeframe

26 weeks

Results posted on

2016-02-01

Participant Flow

Participant milestones

Participant milestones
Measure
Argentinean Tango
A biweekly 3-month tango program Argentinean Tango classes: Tango participants will attend an 1-hour Argentinean Tango classes twice a week during 12 weeks, with experienced professional tango instructors.
A 'Wait-list' Control Group
Patient information about exercise in PD. After 12 weeks, these patients will then start the same 12-weeks tango program. Simple pamphlet about the exercise in PD: Controls will follow their usual schedule of pharmacological treatment; will be provided by simple pamphlet about the exercise in PD, and will otherwise to go about their lives as usual.
Overall Study
STARTED
18
15
Overall Study
COMPLETED
18
15
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Tango for Treatment of Motor and Non-motor Manifestations in Parkinson's Disease.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Control
n=15 Participants
Tango
n=18 Participants
Total
n=33 Participants
Total of all reporting groups
Age, Continuous
64.3 years
STANDARD_DEVIATION 8.1 • n=99 Participants
63.2 years
STANDARD_DEVIATION 9.9 • n=107 Participants
63.7 years
STANDARD_DEVIATION 9.08 • n=206 Participants
Sex: Female, Male
Female
8 Participants
n=99 Participants
6 Participants
n=107 Participants
14 Participants
n=206 Participants
Sex: Female, Male
Male
7 Participants
n=99 Participants
12 Participants
n=107 Participants
19 Participants
n=206 Participants
Disease duration
7.7 years
STANDARD_DEVIATION 4.6 • n=99 Participants
5.5 years
STANDARD_DEVIATION 4.4 • n=107 Participants
6.5 years
STANDARD_DEVIATION 4.49 • n=206 Participants

PRIMARY outcome

Timeframe: 26 weeks

This is the standard scale used for grading severity of PD. It starts with a patient self-administered questionnaire covering activities of daily living, motor symptoms, and non-motor domains. It also includes a systematic rated clinical interview assessing cognitive and psychiatric symptoms and motor complications of disease. A Hoehn and Yahr scale (5-point overall disease severity index) is included. Finally, there is a formal examination component (Part III) (performed in the medication 'on' state for this study). Total score for Unified Parkinson Disease Rating Scale is the sum of six subscales, ranging from 0 (best possible outcome) to 60 (worst possible symptoms)

Outcome measures

Outcome measures
Measure
Argentinean Tango
n=18 Participants
A biweekly 3-month tango program Argentinean Tango classes: Tango participants will attend an 1-hour Argentinean Tango classes twice a week during 12 weeks, with experienced professional tango instructors.
A 'Wait-list' Control Group
n=15 Participants
Patient information about exercise in PD. After 12 weeks, these patients will then start the same 12-weeks tango program. Simple pamphlet about the exercise in PD: Controls will follow their usual schedule of pharmacological treatment; will be provided by simple pamphlet about the exercise in PD, and will otherwise to go about their lives as usual.
Severity of PD (Unified Parkinson Disease Rating Scale - UPDRS, 2008 Version)
baseline
24.7 units on a scale
Standard Deviation 9.6
30.5 units on a scale
Standard Deviation 13.6
Severity of PD (Unified Parkinson Disease Rating Scale - UPDRS, 2008 Version)
follow-up
24.4 units on a scale
Standard Deviation 10.8
30.2 units on a scale
Standard Deviation 12.0

SECONDARY outcome

Timeframe: 26 weeks

Balance will be assessed using a 14-item tool measuring performance of dynamic balance tasks. This test has high interrater and test-retest reliability in PD (intraclass correlation coefficient ≥ .92 and intraclass correlation coefficient ≥.88 respectively). Total score for MiniBESTest is the sum of foursubscales, ranging from 0 (worst possible balance) to 28 (best possible balance). Lower scores indicate greater deficits in balance. Two items have right and left assessment in which the lower score is used within the total score (directions specify which to use). For research, we used of both left and right data, thus calculating data based on 32 (vs 28) points.

Outcome measures

Outcome measures
Measure
Argentinean Tango
n=18 Participants
A biweekly 3-month tango program Argentinean Tango classes: Tango participants will attend an 1-hour Argentinean Tango classes twice a week during 12 weeks, with experienced professional tango instructors.
A 'Wait-list' Control Group
n=15 Participants
Patient information about exercise in PD. After 12 weeks, these patients will then start the same 12-weeks tango program. Simple pamphlet about the exercise in PD: Controls will follow their usual schedule of pharmacological treatment; will be provided by simple pamphlet about the exercise in PD, and will otherwise to go about their lives as usual.
MiniBESTest
Baseline
28.3 units on a scale
Standard Deviation 2.3
27.1 units on a scale
Standard Deviation 3.9
MiniBESTest
Follow-up
28.8 units on a scale
Standard Deviation 0.4
26.0 units on a scale
Standard Deviation 4.3

SECONDARY outcome

Timeframe: 26 weeks

Falls will be assessed using an adapted version of the falls questionnaire from the Canadian Longitudinal Study of Aging focusing on the past 3 months. This questionnaire includes 2 questions to assess if the participants felt during the past year and then it assess if this fall happened within the last 3 months. If a participant answered 'yes' to both questions, then the participant screened positive for this outcome. In the results section, we reported the number of participant who answered 'Yes' to both questions.

Outcome measures

Outcome measures
Measure
Argentinean Tango
n=18 Participants
A biweekly 3-month tango program Argentinean Tango classes: Tango participants will attend an 1-hour Argentinean Tango classes twice a week during 12 weeks, with experienced professional tango instructors.
A 'Wait-list' Control Group
n=15 Participants
Patient information about exercise in PD. After 12 weeks, these patients will then start the same 12-weeks tango program. Simple pamphlet about the exercise in PD: Controls will follow their usual schedule of pharmacological treatment; will be provided by simple pamphlet about the exercise in PD, and will otherwise to go about their lives as usual.
Number of Participants With a Fall in the Past 3 Months Using the Falls Questionnaire From the Canadian Longitudinal Study of Aging
0 participants
1 participants

SECONDARY outcome

Timeframe: 26 weeks

Freezing of gait will be assessed using the Freezing of Gait Questionnare (FOG\_Q), a 6-item tool measuring walking and freezing episodes. Higher scores indicate greater difficulty with walking and freezing. Six items each scored from 0 to 6 were summed to obtain the total score, ranging from 0 (best possible outcome) to 36 (worst possible outcome).

Outcome measures

Outcome measures
Measure
Argentinean Tango
n=18 Participants
A biweekly 3-month tango program Argentinean Tango classes: Tango participants will attend an 1-hour Argentinean Tango classes twice a week during 12 weeks, with experienced professional tango instructors.
A 'Wait-list' Control Group
n=15 Participants
Patient information about exercise in PD. After 12 weeks, these patients will then start the same 12-weeks tango program. Simple pamphlet about the exercise in PD: Controls will follow their usual schedule of pharmacological treatment; will be provided by simple pamphlet about the exercise in PD, and will otherwise to go about their lives as usual.
Freezing of Gait Questionnare (FOG_Q)
Baseline
2.0 units on a scale
Standard Deviation 2.5
4.6 units on a scale
Standard Deviation 5.9
Freezing of Gait Questionnare (FOG_Q)
Follow-up
2.7 units on a scale
Standard Deviation 3.8
4.1 units on a scale
Standard Deviation 4.2

SECONDARY outcome

Timeframe: 26 weeks

The Purdue Pegboard, a test of dexterity and speed in the hands will be assessed over 1 minute. We calculate the number of pins correctly placed on the board in a minute.

Outcome measures

Outcome measures
Measure
Argentinean Tango
n=18 Participants
A biweekly 3-month tango program Argentinean Tango classes: Tango participants will attend an 1-hour Argentinean Tango classes twice a week during 12 weeks, with experienced professional tango instructors.
A 'Wait-list' Control Group
n=15 Participants
Patient information about exercise in PD. After 12 weeks, these patients will then start the same 12-weeks tango program. Simple pamphlet about the exercise in PD: Controls will follow their usual schedule of pharmacological treatment; will be provided by simple pamphlet about the exercise in PD, and will otherwise to go about their lives as usual.
The Purdue Pegboard
Follow-up
13.8 correct pins per 60 sec
Standard Deviation 2.4
12.5 correct pins per 60 sec
Standard Deviation 3.1
The Purdue Pegboard
Baseline
14.4 correct pins per 60 sec
Standard Deviation 2.0
13.1 correct pins per 60 sec
Standard Deviation 2.9

SECONDARY outcome

Timeframe: 26 weeks

This tool was designed to screen for mild cognitive impairment. This includes visuospatial tests (clock drawing, trail making, cube copying), confrontation naming, attention (digit span, backwards digit span, "A" test, sentence repetition), tests of verbal fluency, abstraction, short term memory, and orientation. Recently, it has been used widely in PD, and demonstrates excellent sensitivity for subtle cognitive deficits. Alternate versions (7.1 to 7.3, with a randomly-distributed order) will be administered to prevent training effects. Total score for the MoCA is the sum of eight subscales, ranging from 0 (worst possible outcome) to 30 (best possible symptoms)"

Outcome measures

Outcome measures
Measure
Argentinean Tango
n=18 Participants
A biweekly 3-month tango program Argentinean Tango classes: Tango participants will attend an 1-hour Argentinean Tango classes twice a week during 12 weeks, with experienced professional tango instructors.
A 'Wait-list' Control Group
n=15 Participants
Patient information about exercise in PD. After 12 weeks, these patients will then start the same 12-weeks tango program. Simple pamphlet about the exercise in PD: Controls will follow their usual schedule of pharmacological treatment; will be provided by simple pamphlet about the exercise in PD, and will otherwise to go about their lives as usual.
The Montreal Cognitive Assessment
Follow-up
27.4 score
Standard Deviation 2.1
26.1 score
Standard Deviation 3.2
The Montreal Cognitive Assessment
Baseline
27.0 score
Standard Deviation 2.4
26.7 score
Standard Deviation 2.8

SECONDARY outcome

Timeframe: 26 weeks

The BDI is a self-administered scale of 21 items (scored 0-3) which assesses depression symptoms. The Beck Inventory is one of the most commonly-used scales for depression in PD, and a recent consensus panel of the Movement Disorders Society concluded it was a scale of first choice for assessing depression in PD. Total score for the BDI is the sum of 21 items, ranging from 0 (best possible outcome) to 63 (worst possible symptoms)"

Outcome measures

Outcome measures
Measure
Argentinean Tango
n=18 Participants
A biweekly 3-month tango program Argentinean Tango classes: Tango participants will attend an 1-hour Argentinean Tango classes twice a week during 12 weeks, with experienced professional tango instructors.
A 'Wait-list' Control Group
n=15 Participants
Patient information about exercise in PD. After 12 weeks, these patients will then start the same 12-weeks tango program. Simple pamphlet about the exercise in PD: Controls will follow their usual schedule of pharmacological treatment; will be provided by simple pamphlet about the exercise in PD, and will otherwise to go about their lives as usual.
The Beck Depression Inventory (BDI)
Baseline
7.9 score
Standard Deviation 6.6
7.7 score
Standard Deviation 5.3
The Beck Depression Inventory (BDI)
Follow-up
7.7 score
Standard Deviation 7.2
7.3 score
Standard Deviation 4.4

SECONDARY outcome

Timeframe: 26 weeks

This is a 14-item patient-rated scale which measures cognitive, emotional, and behavioural symptoms of apathy. All items are rated on a 0 to 3 Likert Scale. The original 18-item scale has been shortened by four items, and wording simplified and it was reported to have excellent psychometric properties in PD (internal consistency reliability = 0.76, test-retest 1 week r = 0.90). Total score is ranging from 0 (best possible outcome) to 42 (worst possible symptoms).

Outcome measures

Outcome measures
Measure
Argentinean Tango
n=18 Participants
A biweekly 3-month tango program Argentinean Tango classes: Tango participants will attend an 1-hour Argentinean Tango classes twice a week during 12 weeks, with experienced professional tango instructors.
A 'Wait-list' Control Group
n=15 Participants
Patient information about exercise in PD. After 12 weeks, these patients will then start the same 12-weeks tango program. Simple pamphlet about the exercise in PD: Controls will follow their usual schedule of pharmacological treatment; will be provided by simple pamphlet about the exercise in PD, and will otherwise to go about their lives as usual.
Apathy Evaluation Scale (AES)
Baseline
28.9 score
Standard Deviation 7.3
26.8 score
Standard Deviation 7.6
Apathy Evaluation Scale (AES)
Follow-up
31.3 score
Standard Deviation 4.5
29.4 score
Standard Deviation 5.9

SECONDARY outcome

Timeframe: 26 weeks

The fatigue severity scale measures impact of fatigue with a 9-item questionnaire, with a 7-point Likert scale for each question It has been validated, and has been used in PD studies. Total score is ranging from 0 (best possible outcome) to 63 (worst possible fatigue).

Outcome measures

Outcome measures
Measure
Argentinean Tango
n=18 Participants
A biweekly 3-month tango program Argentinean Tango classes: Tango participants will attend an 1-hour Argentinean Tango classes twice a week during 12 weeks, with experienced professional tango instructors.
A 'Wait-list' Control Group
n=15 Participants
Patient information about exercise in PD. After 12 weeks, these patients will then start the same 12-weeks tango program. Simple pamphlet about the exercise in PD: Controls will follow their usual schedule of pharmacological treatment; will be provided by simple pamphlet about the exercise in PD, and will otherwise to go about their lives as usual.
The Krupp Fatigue Severity Scale
Baseline
34.3 score
Standard Deviation 12.2
33.3 score
Standard Deviation 14.2
The Krupp Fatigue Severity Scale
Follow-up
30.8 score
Standard Deviation 15.3
35.9 score
Standard Deviation 11.9

SECONDARY outcome

Timeframe: 26 weeks

The PDQ-39 is a quality of life index for PD. It consists of a 39-item questionnaire that asks about the impact of PD on a person's motor function, gait, mood, cognition, and activities of daily living. Patients are asked to indicate the frequency of each event by selecting one of 5 options: never/occasionally/sometimes/often/always or cannot do at all. Total score is ranging from 0 (best possible outcome) to 156 (worst possible quality of life).

Outcome measures

Outcome measures
Measure
Argentinean Tango
n=18 Participants
A biweekly 3-month tango program Argentinean Tango classes: Tango participants will attend an 1-hour Argentinean Tango classes twice a week during 12 weeks, with experienced professional tango instructors.
A 'Wait-list' Control Group
n=15 Participants
Patient information about exercise in PD. After 12 weeks, these patients will then start the same 12-weeks tango program. Simple pamphlet about the exercise in PD: Controls will follow their usual schedule of pharmacological treatment; will be provided by simple pamphlet about the exercise in PD, and will otherwise to go about their lives as usual.
The Parkinson's Disease Questionnaire is a Quality of Life(PDQ-39)
Baseline
26.8 score
Standard Deviation 17.1
25.8 score
Standard Deviation 15.1
The Parkinson's Disease Questionnaire is a Quality of Life(PDQ-39)
Follow-up
26.4 score
Standard Deviation 18.9
24.5 score
Standard Deviation 12.9

SECONDARY outcome

Timeframe: 12 weeks

Compliance with dance therapy will be conducted by reconfirming the regular assistance to the dance sessions at week 12, to compare how many sessions were attended by the participants. The dance instructors will keep the track of dance classes' assistance.

Outcome measures

Outcome measures
Measure
Argentinean Tango
n=18 Participants
A biweekly 3-month tango program Argentinean Tango classes: Tango participants will attend an 1-hour Argentinean Tango classes twice a week during 12 weeks, with experienced professional tango instructors.
A 'Wait-list' Control Group
n=15 Participants
Patient information about exercise in PD. After 12 weeks, these patients will then start the same 12-weeks tango program. Simple pamphlet about the exercise in PD: Controls will follow their usual schedule of pharmacological treatment; will be provided by simple pamphlet about the exercise in PD, and will otherwise to go about their lives as usual.
Adherence to Treatment
6 participants
0 participants

SECONDARY outcome

Timeframe: 26 weeks

Completed by both the examiner and the patient, the scale is a single question" Since you have enrolled in the study, how has your Parkinson's disease changed?". It will be scored as very much improved (6), much improved (5), minimally improved (4), no change (3), minimally worse (2), much worse (1), or very much worse(0).

Outcome measures

Outcome measures
Measure
Argentinean Tango
n=18 Participants
A biweekly 3-month tango program Argentinean Tango classes: Tango participants will attend an 1-hour Argentinean Tango classes twice a week during 12 weeks, with experienced professional tango instructors.
A 'Wait-list' Control Group
n=15 Participants
Patient information about exercise in PD. After 12 weeks, these patients will then start the same 12-weeks tango program. Simple pamphlet about the exercise in PD: Controls will follow their usual schedule of pharmacological treatment; will be provided by simple pamphlet about the exercise in PD, and will otherwise to go about their lives as usual.
Clinical Global Impression of Change
3.4 units on a scale
Standard Deviation 1.3
3 units on a scale
Standard Deviation 1

SECONDARY outcome

Timeframe: 12 weeks

An exit questionnaire ranking level of enjoyment and overall satisfaction with their dance/exercise program, scored from 1 (strongly agree) to 5 (strongly disagree), with open questions about willingness continuing practicing tango.

Outcome measures

Outcome measures
Measure
Argentinean Tango
n=18 Participants
A biweekly 3-month tango program Argentinean Tango classes: Tango participants will attend an 1-hour Argentinean Tango classes twice a week during 12 weeks, with experienced professional tango instructors.
A 'Wait-list' Control Group
n=15 Participants
Patient information about exercise in PD. After 12 weeks, these patients will then start the same 12-weeks tango program. Simple pamphlet about the exercise in PD: Controls will follow their usual schedule of pharmacological treatment; will be provided by simple pamphlet about the exercise in PD, and will otherwise to go about their lives as usual.
Exit Questionnaire
Finding tango or exercise enjoyable
1.1 units on a scale
Standard Deviation 0.3
2.1 units on a scale
Standard Deviation 0.9
Exit Questionnaire
Feeling overall satisfaction
1.1 units on a scale
Standard Deviation 0.3
2 units on a scale
Standard Deviation 0.8

SECONDARY outcome

Timeframe: 12 weeks

Adverse events will be queried week 12 through a semi structured interview querying increase in falls, fatigue, pain, cramps or pain, in addition to open-ended questions regarding other potential adverse events. Events will be rated by the patient and investigator as mild, moderate, or serious. All serious adverse events will be reported to the research ethics board

Outcome measures

Outcome measures
Measure
Argentinean Tango
n=18 Participants
A biweekly 3-month tango program Argentinean Tango classes: Tango participants will attend an 1-hour Argentinean Tango classes twice a week during 12 weeks, with experienced professional tango instructors.
A 'Wait-list' Control Group
n=15 Participants
Patient information about exercise in PD. After 12 weeks, these patients will then start the same 12-weeks tango program. Simple pamphlet about the exercise in PD: Controls will follow their usual schedule of pharmacological treatment; will be provided by simple pamphlet about the exercise in PD, and will otherwise to go about their lives as usual.
Adverse Events
22 percentage of participants
13 percentage of participants

Adverse Events

Argentinean Tango

Serious events: 0 serious events
Other events: 4 other events
Deaths: 0 deaths

A 'Wait-list' Control Group

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Argentinean Tango
n=18 participants at risk
A biweekly 3-month tango program Argentinean Tango classes: Tango participants will attend an 1-hour Argentinean Tango classes twice a week during 12 weeks, with experienced professional tango instructors.
A 'Wait-list' Control Group
n=15 participants at risk
Patient information about exercise in PD. After 12 weeks, these patients will then start the same 12-weeks tango program. Simple pamphlet about the exercise in PD: Controls will follow their usual schedule of pharmacological treatment; will be provided by simple pamphlet about the exercise in PD, and will otherwise to go about their lives as usual.
Musculoskeletal and connective tissue disorders
Falls
11.1%
2/18
13.3%
2/15
Infections and infestations
respiratory infection
5.6%
1/18
0.00%
0/15
Musculoskeletal and connective tissue disorders
mild fatigue and muscle cramps
5.6%
1/18
0.00%
0/15

Additional Information

Dr.Ronald B Postuma

McGill University

Phone: 514-934-8026

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place